Hugo López-Gatell clarified that although the pharmaceutical company Janssen already has the approval to carry out its phase 3 clinical trial in Mexico, there is still no purchase commitment
Five months after the new normal, in Mexico, deaths from covid-19 rose to 93,228 due to the report of 635 new deaths.
In addition, there are 541 suspicious deaths with the possibility of a result, 10,593 from which a sample was not taken and 4,274 deaths that will not have a result.
There are 943 thousand 630 confirmed cases of coronavirus, due to the record of 5 thousand 225 new infections.
With regard to suspected cases, there are 185 thousand 701 without a sample; 62 thousand 458 with possibility of result and 108 thousand 132 that will not have it.
The estimated active cases are 45,512 and 697,402, people who have recovered from the disease.
Hospital occupancy, as of November 3, was 12,435 occupied beds, which is equivalent to 31 percent. In general beds, occupancy was 33 percent and in beds with a fan, 26 percent.
COVID-19 IN HEALTH PERSONNEL
The pandemic has claimed the lives of 1,884 health workers with the report of 140,196 confirmed accumulated cases, where 61 percent are women.
Three thousand 362 are the health professionals who have fallen ill in the last 15 days.
The most affected areas are, firstly, nursing, with 41 percent of the cases. In second place, “other health workers”, with 29 percent.
It is followed by male and female doctors, with 26%. In fourth place, laboratory specialists, with 2%, and dentists, in last place, with 1%.
The Undersecretary of Health, Hugo López-Gatell Ramírez, reported that Mexico made a “pre-purchase” with an initial deposit to acquire 51 million vaccines against the coronavirus, through the mechanism of Global Access to vaccines against covid-19, called Covax, promoted by the World Health Organization (WHO) and other organizations.
However, he added that these doses are insufficient for the country, so there is the financial capacity to acquire a greater number with three other “pre-purchase” options, which were negotiated – separately – with the Pfizer, Astra Zeneca and CanSino laboratories. Biologics.
He clarified that although the pharmaceutical company Janssen already has the approval to carry out its phase 3 clinical trial in Mexico, there is still no purchase commitment.
The pre-purchase commitments were signed a couple of weeks ago. These pre-purchase commitments, what they allow is to guarantee access. They are not yet contracts, they are commitments that help the Mexican government to have timely and facilitated access, ”the official explained at the afternoon conference.
You can also read:
Copyright law strictly prohibits copying all or part of Excelsior materials without first obtaining written permission and without including the link to the original text.